文献速递免疫规划妇幼与学校卫生

美国军人妊娠期启动COVID-19疫苗接种与不良新生儿结局风险,2021年1月至12月

COVID-19 vaccine initiation in pregnancy and risk for adverse neonatal outcomes among United States military service members, January-December 2021.
PubMed 文献 · Vaccine · 2025-02-18

这项回顾性队列研究纳入2021年美国现役军人7184例单胎活产,其中2867例(39.9%)在妊娠期接种首剂COVID-19疫苗。经逆概率加权并调整妊娠期SARS-CoV-2感染后,妊娠期启动接种与早产、小于胎龄儿、低出生体重或新生儿重症监护病房入院均无关联。

要点

  • 妊娠期启动COVID-19疫苗接种与早产风险无关联(调整HR 1.02,95%CI 0.83-1.26)。
  • 与小于胎龄儿(调整HR 1.01,95%CI 0.78-1.30)和低出生体重(调整HR 1.01,95%CI 0.80-1.28)无关联。
  • 与新生儿重症监护病房入院无关联(调整RR 0.90,95%CI 0.75-1.07)。

核心结论

  • 妊娠期接种COVID-19疫苗基础系列与所研究的不良新生儿结局风险升高无关,印证了现有文献的发现。

研究设计与样本

  • 回顾性队列研究,利用国防部出生与婴儿健康研究项目数据,识别2021年美国现役军人单胎活产,共纳入7184例。

主要发现

  • 2867例(39.9%)在妊娠期接种首剂COVID-19疫苗,4317例(60.1%)在妊娠期或妊娠前未接种任何COVID-19疫苗。
  • 应用权重后,暴露组与非暴露组之间的基线差异(如年龄、种族和族裔、婚姻状况、职业)完全衰减。
  • 妊娠期启动COVID-19疫苗接种与早产(<37周妊娠;调整HR 1.02,95%CI 0.83-1.26)无关联。
  • 与小于胎龄儿(<第10百分位;调整HR 1.01,95%CI 0.78-1.30)和低出生体重(<2500 g;调整HR 1.01,95%CI 0.80-1.28)无关联。
  • 与新生儿重症监护病房入院无关联(调整RR 0.90,95%CI 0.75-1.07)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The safety of primary series COVID-19 vaccine exposure in pregnancy has been well-studied; however, no research to date has been conducted among United States (US) military service members, a unique population with specific vaccination requirements for active duty service and early COVID-19 vaccine access. METHODS: This retrospective cohort study leveraged data from the Department of Defense Birth and Infant Health Research program to identify live births among active duty US military service members in calendar year 2021. Administrative military personnel data, immunization files, and medical encounter records were used to develop study variables and determine COVID-19 vaccine receipt in pregnancy. Cox and modified Poisson regression models estimated hazard (HR) and risk ratios (RR), respectively, with 95 % confidence intervals (CI) for vaccine receipt and selected neonatal outcomes; models were adjusted for baseline characteristics using inverse probability of treatment weighting and further adjusted for SARS-CoV-2 infection in pregnancy. RESULTS: There were 7184 singleton live births included for analysis, of which 2867 (39.9 %) were among service members exposed to their first COVID-19 vaccine dose in pregnancy and 4317 (60.1 %) among service members unexposed to any COVID-19 vaccine during or prior to pregnancy. Baseline differences between exposed and unexposed service members (e.g., age, race and ethnicity, marital status, occupation) were fully attenuated after applying weights. COVID-19 vaccine initiation in pregnancy was not associated with preterm birth (<37 weeks' gestation; adjusted HR: 1.02, 95 % CI: 0.83-1.26), small for gestational age (<10th percentile; adjusted HR: 1.01, 95 % CI: 0.78-1.30), low birthweight (<2500 g; adjusted HR: 1.01, 95 % CI: 0.80-1.28), or neonatal intensive care unit admission (adjusted RR: 0.90, 95 % CI: 0.75-1.07). CONCLUSION: Primary series COVID-19 vaccine exposure in pregnancy was common in this military cohort. Vaccine receipt was not associated with increased risk for any adverse outcome under study, substantiating findings from existing literature.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hall C, Lanning J, Romano CJ, et al. COVID-19 vaccine initiation in pregnancy and risk for adverse neonatal outcomes among United States military service members, January-December 2021. Vaccine. 2025. PMID: 39970594. doi:10.1016/j.vaccine.2025.126894

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。